Search research articles
Contact Us
Filters
Showing results (51-60 of 89) with videos related to
Page
of 9
Sort By:
Journal of Clinical Gastroenterology
|
June 9, 2005
Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related?
Chi Ming Lam, Jamy L Yong, Annie O Chan, et al.
International Journal of Oncology
|
January 5, 2007
Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway
Kevin T Ng, Kwan Man, Joanna W Ho, et al.
Japanese Journal of Clinical Oncology
|
September 28, 2010
Liver Cancer Working Group report
Masatoshi Kudo, Kwang Hyub Han, Norihiro Kokudo, et al.
Carcinogenesis
|
September 4, 2008
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation
Chris K Sun, Kwan Man, Kevin T Ng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 31, 2008
PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling
Yuqing Liu, Eric Lik Hang Lui, Scott L Friedman, et al.
Asian Journal of Surgery
|
March 8, 2011
Laparoscopic liver resection for hepatocellular carcinoma
Carmen D Chung, Lydia L Lau, Kwan Lung Ko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database
Matan J Cohen, Izhar Levy, Orly Barak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma
Ronnie T Poon, Ka Kit Chung, Siu Tim Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics
Thomas Yau, Pei-Jer Chen, Pierre Chan, et al.
Carcinogenesis
|
December 18, 2004
Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target
Terence K Lee, Kwan Man, Joanna W Ho, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 89) with videos related to
Sort By:
Page
of 9
Journal of Clinical Gastroenterology
|
June 9, 2005
Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related?
Chi Ming Lam, Jamy L Yong, Annie O Chan, et al.
International Journal of Oncology
|
January 5, 2007
Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway
Kevin T Ng, Kwan Man, Joanna W Ho, et al.
Japanese Journal of Clinical Oncology
|
September 28, 2010
Liver Cancer Working Group report
Masatoshi Kudo, Kwang Hyub Han, Norihiro Kokudo, et al.
Carcinogenesis
|
September 4, 2008
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation
Chris K Sun, Kwan Man, Kevin T Ng, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 31, 2008
PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling
Yuqing Liu, Eric Lik Hang Lui, Scott L Friedman, et al.
Asian Journal of Surgery
|
March 8, 2011
Laparoscopic liver resection for hepatocellular carcinoma
Carmen D Chung, Lydia L Lau, Kwan Lung Ko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database
Matan J Cohen, Izhar Levy, Orly Barak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma
Ronnie T Poon, Ka Kit Chung, Siu Tim Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics
Thomas Yau, Pei-Jer Chen, Pierre Chan, et al.
Carcinogenesis
|
December 18, 2004
Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target
Terence K Lee, Kwan Man, Joanna W Ho, et al.
Page
of 9